[go: up one dir, main page]

 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (2,483)

Search Parameters:
Keywords = cells classification

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
39 pages, 1155 KiB  
Review
Targeted Therapy in Breast Cancer: Advantages and Advancements of Antibody–Drug Conjugates, a Type of Chemo-Biologic Hybrid Drugs
by Attrayo Mukherjee and Debasish Bandyopadhyay
Cancers 2024, 16(20), 3517; https://doi.org/10.3390/cancers16203517 - 17 Oct 2024
Abstract
Cancer is a significant health challenge globally, with millions of people affected every year, resulting in high morbidity and mortality. Although other treatment options are available with limitations, chemotherapy, either standalone or combined with other therapeutic procedures, is the most commonly used practice [...] Read more.
Cancer is a significant health challenge globally, with millions of people affected every year, resulting in high morbidity and mortality. Although other treatment options are available with limitations, chemotherapy, either standalone or combined with other therapeutic procedures, is the most commonly used practice of treating cancer. In chemotherapy, cancer cells/malignant tumors are targeted; however, due to less target specificity, along with malignant cells, normal cells are also affected, which leads to various off-target effects (side effects) that impact the patient quality of life. Out of all the different types of cancers, breast cancer is the most common type of cancer in humans worldwide. Current anticancer drug discovery research aims to develop therapeutics with higher potency and lower toxicity, which is only possible through target-specific therapy. Antibody–drug conjugates (ADCs) are explicitly designed to target malignant tumors and minimize off-target effects by reducing systemic cytotoxicity. Several ADCs have been approved for clinical use and have shown moderate to good efficacy so far. Considering various aspects, chemotherapy and ADCs are useful in treating cancer. However, ADCs provide a more focused and less toxic approach, which is especially helpful in cases where resistance to chemotherapy (drug resistance) occurs and in the type of malignancies in which specific antigens are overexpressed. Ongoing ADC research aims to develop more target-specific cancer treatments. In short, this study presents a concise overview of ADCs specific to breast cancer treatment. This study provides insight into the classifications, mechanisms of action, structural aspects, and clinical trial phases (current status) of these chemo-biologic drugs (ADCs). Full article
(This article belongs to the Special Issue New Perspectives in the Management of Breast Cancer)
Show Figures

Figure 1

Figure 1
<p>Representative mechanistic pathway of ADC in cancer cells.</p>
Full article ">Figure 2
<p>Chemical structures of the drugs (payloads) used to prepare anti-breast cancer ADCs (<a href="#cancers-16-03517-t001" class="html-table">Table 1</a>).</p>
Full article ">Figure 2 Cont.
<p>Chemical structures of the drugs (payloads) used to prepare anti-breast cancer ADCs (<a href="#cancers-16-03517-t001" class="html-table">Table 1</a>).</p>
Full article ">
16 pages, 3825 KiB  
Article
Evolutionary Grid Optimization and Deep Learning for Improved In Vitro Cellular Spheroid Localization
by Jonas Schurr, Hannah Janout, Andreas Haghofer, Marian Fürsatz, Josef Scharinger, Stephan Winkler and Sylvia Nürnberger
Appl. Sci. 2024, 14(20), 9476; https://doi.org/10.3390/app14209476 - 17 Oct 2024
Viewed by 123
Abstract
The recently developed high-throughput system for cell spheroid generation (SpheroWell) is a promising technology for cost- and time-efficient in vitro analysis of, for example, chondrogenic differentiation. It is a compartmental growth surface where spheroids develop from a cell monolayer by self-assembling and aggregation. [...] Read more.
The recently developed high-throughput system for cell spheroid generation (SpheroWell) is a promising technology for cost- and time-efficient in vitro analysis of, for example, chondrogenic differentiation. It is a compartmental growth surface where spheroids develop from a cell monolayer by self-assembling and aggregation. In order to automatize the analysis of spheroids, we aimed to develop imaging software and improve the localization of cell compartments and fully formed spheroids. Our workflow provides automated detection and localization of spheroids in different formation stages within Petri dishes based on images created with a low-budget camera imaging setup. This automated detection enables a fast and inexpensive analysis workflow by processing a stack of images within a short period of time, which is essential for the extraction of early readout parameters. Our workflow combines image processing algorithms and deep learning-based image localization/segmentation methods like Mask R-CNN and Unet++. These methods are refined by an evolution strategy for automated grid detection, which is able to improve the overall segmentation and classification quality. Besides the already pre-trained neural networks and predefined image processing parameters, our evolution-based post-processing provides the required adaptability for our workflow to deliver a consistent and reproducible quality. This is especially important due to the use of a low-budget imaging setup with various light conditions. The to-be-detected objects of the three different stages show improved results using our evolutionary post-processing for monolayer and starting aggregation with Dice coefficients of 0.7301 and 0.8562, respectively, compared with the raw scores of 0.2879 and 0.8187. The Dice coefficient of the fully formed spheroids in both cases is 0.8829. With our algorithm, we provide automated analyses of cell spheroid by self-assembling in SpheroWell dishes, even if the images are created using a low-budget camera setup. Full article
(This article belongs to the Special Issue Evolutionary Algorithms and Their Real-World Applications)
Show Figures

Figure 1

Figure 1
<p>Example of a SpheroWell Petri dish image (<b>left</b>) with the individual states of forming spheroids as well as the corresponding object labels on the (<b>right</b>). Each labeled object is drawn by a polygon, and its intensity value represents a unique identification number. This number is used for additional data files, including the corresponding class label for each identification number.</p>
Full article ">Figure 2
<p>We used our dataset of 20 images of Petri dishes, along with class and object labels, to create and validate individual workflow modules. For the creation of our segmentation/instance segmentation models, we split the initial images into three datasets (training, validation, and testing). Using the training and validation split, we created our Mask R-CNN and our Unet++. Using our validation dataset, we selected the best model for both architectures based on the validation loss. The final testing of our model was split into two parts (binary segmentation and object detection), both using the test dataset. Solely using the Petri dish images without class labels, our evolutionary grid optimization created a grid for each of our images. Based on these grids, we created and tested our parameters for the grid-based filtering. The final testing of our workflow was also based on the separate test dataset.</p>
Full article ">Figure 3
<p>Overview of steps for the evolution strategy. 1: Extracted Petri dish with Hough Circles (insufficient extraction of grid cells), 2: Extracted Hough Lines 3: grid of a solution candidate, 4: Compute fitness of solution candidates with overlap based on Dice coefficient, 5: Final results.</p>
Full article ">Figure 4
<p>Simplified representation of the whole classification workflow, starting with the image of a Petri dish carrying the individual objects. Based on this image, our workflow generates a grid using the evolution strategy-based optimization process and provides the position of each grid cell, as well as a classification mask of all individual objects determined by our neural network. Both of these results are fed into the grid filtering mechanism, which processes the classification results based on the grid cells and outputs the final classification result for each object.</p>
Full article ">Figure 5
<p>Comparison of first epoch (<b>A1</b>,<b>B1</b>) and last epoch (<b>A2</b>,<b>B2</b>) of an evolution strategy run. Images A1 and A2 show a grid represented by a solution candidate, and images (<b>B1</b>,<b>B2</b>) show the final solution on the RGB image with the extracted Petri dish. The result clearly shows the improvement resulting in an almost perfectly aligned grid (fitness: 0.0844). Additionally, <b>A</b> and <b>B</b> show the robustness of the evolution strategy to noise and wrong lines of the preprocessing.</p>
Full article ">Figure 6
<p>Comparison of validated parameters and corresponding values used for the line extraction process by fitness value (lowest is best). Showing the influence and robustness of best and most important parameters and their corresponding values. Large differences in the minimum gap parameter can be observed.</p>
Full article ">Figure 7
<p>Comparison of validated parameters and corresponding values used for the ES by fitness value (lowest is best). Showing the influence and robustness of best and most important parameters and their corresponding values. Large differences in population size can be observed.</p>
Full article ">Figure 8
<p>Comparison of validated parameter values used for the ES by Dice coefficient (highest is best) based on a ground truth image for detected lines and corresponding. Showing the influence and robustness of best and most important parameters and their corresponding values. Large differences in population size can be observed.</p>
Full article ">Figure 9
<p>Comparison of the raw classification result and the filtered/corrected version in comparison with the ground truth. (blue: monolayer, green: forming state, yellow: final spheroid).</p>
Full article ">
15 pages, 1609 KiB  
Article
The Prospect of Improving Pancreatic Cancer Diagnostic Capabilities by Implementing Blood Biomarkers: A Study of Evaluating Properties of a Single IL-8 and in Conjunction with CA19-9, CEA, and CEACAM6
by Tomas Bukys, Benediktas Kurlinkus, Audrius Sileikis and Dalius Vitkus
Biomedicines 2024, 12(10), 2344; https://doi.org/10.3390/biomedicines12102344 (registering DOI) - 15 Oct 2024
Viewed by 389
Abstract
Background/Objectives: This study aims to evaluate the possible clinical application of interleukin 8 (IL-8) as a single biomarker and its capabilities in combination with carbohydrate antigen (CA19-9), carcinoembryonic antigen (CEA), and carcinoembryonic antigen cell adhesion molecule 6 (CEACAM6) as diagnostic and prognostic [...] Read more.
Background/Objectives: This study aims to evaluate the possible clinical application of interleukin 8 (IL-8) as a single biomarker and its capabilities in combination with carbohydrate antigen (CA19-9), carcinoembryonic antigen (CEA), and carcinoembryonic antigen cell adhesion molecule 6 (CEACAM6) as diagnostic and prognostic tools for pancreatic ductal adenocarcinoma (PDAC). Methods: A total of 170 serum samples from patients with PDAC (n = 100), chronic pancreatitis (CP) (n = 39), and healthy individuals (n = 31) were analysed. IL-8 and CEACAM6 were measured by an enzyme-linked immunosorbent assay (ELISA). CA19-9 and CEA were determined by chemiluminescent microparticle immunoassay, and bilirubin was quantified using a diazonium salt reaction. Receiver operating characteristic curve analysis, logistic regression, and Kaplan–Meier analyses were performed to evaluate the properties of a single IL-8 and in combination with other biomarkers. Results: The concentrations of IL-8 were statistically significantly higher in the PDAC group compared to the CP and control groups. Heterogeneous levels of IL-8 correlated with PDAC stages (p = 0.007). IL-8 had good and satisfactory diagnostic efficacy in differentiating PDAC from controls (0.858; p < 0.001) and patients with CP (0.696; p < 0.001), respectively. High and low expressions of IL-8 were not significantly associated with overall survival (OS) or disease-free survival (DFS). A combination of IL-8, CEACAM6, and CA19-9 reached the highest AUC values for differentiating PDAC from the control group. The best classification score between PDAC and the control group with CP patients was obtained by merging IL-8 and CA19-9 (0.894; p < 0.001). Conclusions: These results provide compelling evidence of IL-8 as a promising diagnostic biomarker. Nonetheless, due to the high complexity of PDAC, only the conjunction of IL-8, CA19-9, and CEACAM6 integrates sufficient diagnostic capabilities. Full article
(This article belongs to the Section Cancer Biology and Oncology)
Show Figures

Figure 1

Figure 1
<p>(<b>a</b>) Boxplot of IL-8 serum levels for the control group, patients with PDAC and CP. (<b>b</b>) Box plot of IL-8 serum levels among different PDAC stages (B). IL-8—Interleukin 8. PDAC—Pancreatic ductal adenocarcinoma. CP—Chronic pancreatitis. *— represent potential outliers.</p>
Full article ">Figure 2
<p>ROC curve analysis of IL-8 serum concentrations in patients with PDAC and control group or CP: (<b>a</b>) ROC curve of IL-8 (PDAC and control group); (<b>b</b>) ROC curve of IL-8 (PDAC and CP); (<b>c</b>) Specificity and sensitivity regarding serum IL-8 concentration (PDAC and control group); (<b>d</b>) Specificity and sensitivity in regarding serum IL-8 concentration (PDAC and CP); (<b>e</b>) J regarding serum IL-8 concentration (PDAC and control group); (<b>f</b>) J regarding serum IL-8 concentration (PDAC and CP); (<b>g</b>) ROC curve of all four biomarkers combined (PDAC and control group); (<b>h</b>) ROC curve of all four biomarkers combined (PDAC and CP). IL-8—Interleukin 8. J—Youden index. PDAC—Pancreatic ductal adenocarcinoma. CP—Chronic pancreatitis.</p>
Full article ">Figure 3
<p>Forest plot showing the area under the biomarkers combinations efficiency curve in separate groups. In addition to the analysis, possible sensitivity and specificity were calculated for each biomarker’s combinations. IL-8—Interleukin 8; CEACAM6—Carcinoembryonic antigen cell adhesion molecule 6; CEA—Carcinoembryonic antigen; CA19-9—Carbohydrate antigen 19-9; PDAC—Pancreatic ductal adenocarcinoma; CP—Chronic pancreatitis; AUC—Area under the ROC curve; CI—Confidence interval; <span class="html-italic">p</span>-value—Statistical significance was set at a <span class="html-italic">p</span>-value of less than 0.05.</p>
Full article ">
17 pages, 20880 KiB  
Article
Creating Sustainable Flood Maps Using Machine Learning and Free Remote Sensing Data in Unmapped Areas
by Héctor Leopoldo Venegas-Quiñones, Pablo García-Chevesich, Rodrigo Valdés-Pineda, Ty P. A. Ferré, Hoshin Gupta, Derek Groenendyk, Juan B. Valdés, John E. McCray and Laura Bakkensen
Sustainability 2024, 16(20), 8918; https://doi.org/10.3390/su16208918 - 15 Oct 2024
Viewed by 493
Abstract
This study leverages a Random Forest model to predict flood hazard in Arizona, New Mexico, Colorado, and Utah, focusing on enhancing sustainability in flood management. Utilizing the National Flood Hazard Layer (NFHL), an intricate flood map of Arizona was generated, with the Random [...] Read more.
This study leverages a Random Forest model to predict flood hazard in Arizona, New Mexico, Colorado, and Utah, focusing on enhancing sustainability in flood management. Utilizing the National Flood Hazard Layer (NFHL), an intricate flood map of Arizona was generated, with the Random Forest Classification algorithm assessing flood hazard for each grid cell. Weather variable predictions from TerraClimate were integrated with NFHL classifications and Digital Elevation Model (DEM) analyses, providing a comprehensive understanding of flood dynamics. The research highlights the model’s capability to predict flood hazard in areas lacking NFHL classifications, thereby supporting sustainable flood management by elucidating weather’s influence on flood hazard. This approach aligns with sustainable development goals by aiding in resilient infrastructure design and informed urban planning, reducing the impact of floods on communities. Despite recognizing constraints such as input data precision and the model’s potential limitations in capturing complex variable interactions, the methodology offers a robust framework for flood hazard evaluation in other regions. Integrating diverse data sources, this study presents a valuable tool for decision-makers, supporting sustainable practices, and enhancing the resilience of vulnerable regions against flood hazards. This integrated approach underscores the potential of advanced modeling techniques in promoting sustainability in environmental hazard management. Full article
(This article belongs to the Section Environmental Sustainability and Applications)
Show Figures

Figure 1

Figure 1
<p>Geographic Distribution of FEMA Flood Insurance Rate Maps in the United States.</p>
Full article ">Figure 2
<p>Flowchart showing the development of an RF-based model for estimating NFHL values in New Mexico, Colorado, and Utah using topographic and weather data.</p>
Full article ">Figure 3
<p>(<b>A</b>) National Flood Hazard Layer (NFHL) Analysis in Arizona, New Mexico, Colorado, and Utah: Extracting and Processing Data to Create High-Resolution Flood Maps. (<b>B</b>) NFHL Classification for Arizona. (<b>C</b>) NFHL-Based Flood Hazard Analysis in Arizona Using Grid Cell Classification for Arizona (worst-case threshold).</p>
Full article ">Figure 4
<p>Digital Elevation Model (DEM) analysis of Arizona for flood hazard prediction using USGS 3D Elevation Program (3DEP).</p>
Full article ">Figure 5
<p>TerraClimate weather variables for Arizona.</p>
Full article ">Figure 6
<p>Flood hazard analysis results for Arizona: spatial distribution across different threshold settings.</p>
Full article ">Figure 7
<p>Variable importance based on Gini Index for different scenarios.</p>
Full article ">Figure 8
<p>New flood hazard maps for Utah, Colorado, and New Mexico based on RF classification using Arizona flood hazard map calibration.</p>
Full article ">
16 pages, 2630 KiB  
Article
Blood Growth Factor Levels in Patients with Systemic Lupus Erythematosus: High Neuregulin-1 Is Associated with Comorbid Cardiovascular Pathology
by Evgeny A. Ermakov, Mark M. Melamud, Anastasiia S. Boiko, Svetlana A. Ivanova, Alexey E. Sizikov, Georgy A. Nevinsky and Valentina N. Buneva
Life 2024, 14(10), 1305; https://doi.org/10.3390/life14101305 (registering DOI) - 14 Oct 2024
Viewed by 303
Abstract
Patients with systemic lupus erythematosus (SLE) are known to frequently suffer from comorbid cardiovascular diseases (CVDs). There are abundant data on cytokine levels and their role in the pathogenesis of SLE, while growth factors have received much less attention. The aim of this [...] Read more.
Patients with systemic lupus erythematosus (SLE) are known to frequently suffer from comorbid cardiovascular diseases (CVDs). There are abundant data on cytokine levels and their role in the pathogenesis of SLE, while growth factors have received much less attention. The aim of this study was to analyze growth factor levels in SLE patients and their association with the presence of comorbid CVDs. The serum concentrations for the granulocyte-macrophage colony-stimulating factor (GM-CSF), nerve growth factor β (NGFβ), glial cell line-derived neurotrophic factor (GDNF), and neuregulin-1 β (NRG-1β) were determined in the SLE patients (n = 35) and healthy individuals (n = 38) by a Luminex multiplex assay. The NGFβ and NRG-1β concentrations were shown to be significantly higher in the total group of SLE patients (median [Q1–Q3]: 3.6 [1.3–4.5] and 52.5 [8.5–148], respectively) compared with the healthy individuals (2.9 [1.3–3.4] and 13.7 [4.4–42] ng/mL, respectively). The GM-CSF and GDNF levels did not differ. Interestingly, elevated NRG-1β levels were associated with the presence of CVDs, as SLE patients with CVDs had significantly higher NRG-1β levels (99 [22–242]) compared with the controls (13.7 [4.4–42]) and patients without CVDs (19 [9–80] ng/mL). The model for the binary classification of SLE patients with and without CVDs based on the NRG-1β level had an average predictive ability (AUC = 0.67). Thus, altered levels of growth factors may be associated with comorbid CVDs in SLE patients. Full article
Show Figures

Figure 1

Figure 1
<p>The structure of comorbid CVDs in patients with SLE. (<b>A</b>) Proportions of patients with one, two, and three or more CVDs. (<b>B</b>) Proportions of specific CVDs among SLE patients.</p>
Full article ">Figure 2
<p>Serum concentration of NGFβ (<b>A</b>), GM-CSF (<b>B</b>), NRG-1β (<b>C</b>), GDNF (<b>D</b>) in the total group of SLE patients (n = 35) and healthy individuals (n = 38) determined by Magnetic Luminex assay. The significance of the differences was assessed by the Mann–Whitney test. (<b>E</b>) ROC curve reflecting the quality of binary classification of healthy individuals and SLE patients based on NGFβ and NRG-1β levels.</p>
Full article ">Figure 3
<p>Serum concentrations of NRG-1β in healthy individuals and SLE patients with and without CVDs (<b>A</b>). The significance of the differences was assessed using the Kruskal–Wallis test with Dunn’s post hoc test. (<b>B</b>) ROC curve reflecting the quality of binary classification of SLE patients with and without CVDs based on NRG-1β level.</p>
Full article ">Figure 4
<p>Correlation analysis of serum levels of growth factors with clinical data and cytokine levels in healthy individuals (<b>A</b>), the total group of SLE patients (<b>B</b>), and in subgroups of SLE patients with (<b>C</b>) and without CVDs (<b>D</b>). Correlation heatmaps display color-coded Spearman correlation coefficients. Asterisks indicate significant correlations (*—<span class="html-italic">p</span> &lt; 0.05, **—<span class="html-italic">p</span> &lt; 0.01, ***—<span class="html-italic">p</span> &lt; 0.001).</p>
Full article ">Figure 5
<p>Protein–protein interaction network (<b>A</b>) and co-expression heatmap (<b>B</b>) of cytokines and growth factors investigated in this study. STRING 12.0 online tool was used for protein–protein interaction and co-expression analysis. Protein–protein interaction network (<b>A</b>) reflects known interaction data from curated databases and co-expression analyses. Line thickness indicates the strength of data support. Co-expression heatmap (<b>B</b>) reflects data on gene co-expression scores based on RNA expression patterns and on protein co-regulation provided by ProteomeHD. Instead of protein names, gene names are given in the figures (in particular, the CSF2 gene encodes GM-CSF).</p>
Full article ">
22 pages, 669 KiB  
Review
Molecular Basis of Pancreatic Neuroendocrine Tumors
by Alesia Maluchenko, Denis Maksimov, Zoia Antysheva, Julia Krupinova, Ekaterina Avsievich, Olga Glazova, Natalia Bodunova, Nikolay Karnaukhov, Ilia Feidorov, Diana Salimgereeva, Mark Voloshin and Pavel Volchkov
Int. J. Mol. Sci. 2024, 25(20), 11017; https://doi.org/10.3390/ijms252011017 - 14 Oct 2024
Viewed by 335
Abstract
Pancreatic neuroendocrine tumors (NETs) are rare well-differentiated neoplasms with limited therapeutic options and unknown cells of origin. The current classification of pancreatic neuroendocrine tumors is based on proliferative grading, and guides therapeutic strategies, however, tumors within grades exhibit profound heterogeneity in clinical manifestation [...] Read more.
Pancreatic neuroendocrine tumors (NETs) are rare well-differentiated neoplasms with limited therapeutic options and unknown cells of origin. The current classification of pancreatic neuroendocrine tumors is based on proliferative grading, and guides therapeutic strategies, however, tumors within grades exhibit profound heterogeneity in clinical manifestation and outcome. Manifold studies have highlighted intra-patient differences in tumors at the genetic and transcriptomic levels. Molecular classification might become an alternative or complementary basis for treatment decisions and reflect tumor biology, actionable cellular processes. Here, we provide a comprehensive review of genomic, transcriptomic, proteomic and epigenomic studies of pancreatic NETs to elucidate patterns shared between proposed subtypes that could form a foundation for new classification. We denote four NET subtypes with distinct molecular features, which were consistently reproduced using various omics technologies. Full article
(This article belongs to the Special Issue Emerging Molecular Views in Neuroendocrinology)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Summary of tumor characteristics shared by most specimens within the groups.</p>
Full article ">
13 pages, 2642 KiB  
Study Protocol
Evaluation of Safety and Efficacy of Cell Therapy Based on Osteoblasts Derived from Umbilical Cord Mesenchymal Stem Cells for Osteonecrosis of the Femoral Head: Study Protocol for a Single-Center, Open-Label, Phase I Clinical Trial
by Seung-Hoon Baek, Bum-Jin Shim, Heejae Won, Sunray Lee, Yeon Kyung Lee, Hyun Sook Park and Shin-Yoon Kim
Pharmaceuticals 2024, 17(10), 1366; https://doi.org/10.3390/ph17101366 - 13 Oct 2024
Viewed by 421
Abstract
Although mesenchymal stem cells (MSCs) insertion has gained recent attention as a joint-preserving procedure, no study has conducted direct intralesional implantation of human umbilical cord-derived MSCs (hUCMSCs) in patients with ONFH. This is a protocol for a phase 1 clinical trial designed to [...] Read more.
Although mesenchymal stem cells (MSCs) insertion has gained recent attention as a joint-preserving procedure, no study has conducted direct intralesional implantation of human umbilical cord-derived MSCs (hUCMSCs) in patients with ONFH. This is a protocol for a phase 1 clinical trial designed to assess the safety and exploratory efficacy of human umbilical cord-derived osteoblasts (hUC-Os), osteogenic differentiation-induced cells from hUCMSCs, in patients with early-stage ONFH. Nine patients with Association Research Circulation Osseous (ARCO) stage 1 or 2 will be assigned to a low-dose (1 × 107 hUC-O cells, n = 3), medium-dose (2 × 107 cells, n = 3), and high-dose group (4 × 107 cells, n = 3) in the order of their arrival at the facility, and, depending on the occurrence of dose-limiting toxicity, up to 18 patients can be enrolled by applying the 3 + 3 escalation method. We will perform hUC-O (CF-M801) transplantation combined with core decompression and follow-up for 12 weeks according to the study protocol. Safety will be determined through adverse event assessment, laboratory tests including a panel reactive antibody test, vital sign assessment, physical examination, and electrocardiogram. Efficacy will be explored through the change in pain visual analog scale, Harris hip score, Western Ontario and McMaster Universities Osteoarthritis Index, ARCO stage, and also size and location of necrotic lesion according to Japanese Investigation Committee classification before and after the procedure. Joint preservation is important, particularly in younger, active patients with ONFH. Confirmation of the safety and efficacy of hUC-Os will lead to a further strategy to preserve joints for those suffering from ONFH and improve our current knowledge of cell therapy. Full article
(This article belongs to the Special Issue New Advances in Mesenchymal Stromal Cells as Therapeutic Tools)
Show Figures

Figure 1

Figure 1
<p>A guide pin is inserted under fluoroscopic guidance towards the necrotic area for a core tract. (<b>A</b>) Anterior posterior view. (<b>B</b>) Lateral view.</p>
Full article ">Figure 2
<p>To guide a following hollow reamer, an entry hole is created using a cannulated solid reamer along the guide pin (<b>A</b>), and an autogenous bone chip is collected during reaming (<b>B</b>).</p>
Full article ">Figure 3
<p>A core tract is created for core decompression using a hollow biopsy cannula (<b>A</b>). During this procedure, a cylindrical autogenous bone block is collected, of which a proximal necrotic portion will be sent for pathologic evaluation and a distal viable portion will be implanted as a bone plug after stem cell insertion (<b>B</b>).</p>
Full article ">Figure 4
<p>A curette is inserted to remove the necrotic lesion (<b>A</b>), followed by washing the necrotic bone debris (<b>B</b>).</p>
Full article ">Figure 5
<p>A mixture of cell and collagen putty is implanted into the lesion (black arrow), and the autogenous bone chip and cylindrical bone block is inserted into the remaining space in the core tract (white arrow). If there is significant space remaining in the distal portion of the core tract, a cylindrical hydroxyapatite and tri-calcium phosphate block may be inserted (arrowhead).</p>
Full article ">
11 pages, 1513 KiB  
Article
Identification of Phospholipids Relevant to Cancer Tissue Using Differential Ion Mobility Spectrometry
by Patrik Sioris, Meri Mäkelä, Anton Kontunen, Markus Karjalainen, Antti Vehkaoja, Niku Oksala and Antti Roine
Int. J. Mol. Sci. 2024, 25(20), 11002; https://doi.org/10.3390/ijms252011002 - 13 Oct 2024
Viewed by 430
Abstract
Phospholipids are the main building components of cell membranes and are also used for cell signaling and as energy storages. Cancer cells alter their lipid metabolism, which ultimately leads to an increase in phospholipids in cancer tissue. Surgical energy instruments use electrical or [...] Read more.
Phospholipids are the main building components of cell membranes and are also used for cell signaling and as energy storages. Cancer cells alter their lipid metabolism, which ultimately leads to an increase in phospholipids in cancer tissue. Surgical energy instruments use electrical or vibrational energy to heat tissues, which causes intra- and extracellular water to expand rapidly and degrade cell structures, bursting the cells, which causes the formation of a tissue aerosol or smoke depending on the amount of energy used. This gas phase analyte can then be analyzed via gas analysis methods. Differential mobility spectrometry (DMS) is a method that can be used to differentiate malignant tissue from benign tissues in real time via the analysis of surgical smoke produced by energy instruments. Previously, the DMS identification of cancer tissue was based on a ‘black box method’ by differentiating the 2D dispersion plots of samples. This study sets out to find datapoints from the DMS dispersion plots that represent relevant target molecules. We studied the ability of DMS to differentiate three subclasses of phospholipids (phosphatidylcholine, phosphatidylinositol, and phosphatidylethanolamine) from a control sample using a bovine skeletal muscle matrix with a 5 mg addition of each phospholipid subclass to the sample matrix. We trained binary classifiers using linear discriminant analysis (LDA) and support vector machines (SVM) for sample classification. We were able to identify phosphatidylcholine, -inositol, and -ethanolamine with SVM binary classification accuracies of 91%, 73%, and 66% and with LDA binary classification accuracies of 82%, 74%, and 72%, respectively. Phosphatidylcholine was detected with a reliable classification accuracy, but ion separation setups should be adjusted in future studies to reliably detect other relevant phospholipids such as phosphatidylinositol and phosphatidylethanolamine and improve DMS as a microanalysis method and identify other phospholipids relevant to cancer tissue. Full article
Show Figures

Figure 1

Figure 1
<p>Four-class classification of all of the phospholipid classes, including the control class, using SVM. PC = phosphatidylcholine, PI = phosphatidylinositol, PE = phosphatidylethanolamine.</p>
Full article ">Figure 2
<p>KS test and statistically significant regions of phosphatidylcholine samples.</p>
Full article ">Figure 3
<p>Measurement amounts (n) and excluded measurements.</p>
Full article ">Figure 4
<p>Measurements of PL samples with a diathermy blade. PC = phosphatidylcholine; PI = phosphatidylinositol; PE = phosphatidylethanolamine.</p>
Full article ">
28 pages, 4011 KiB  
Article
Advanced Deep Learning Fusion Model for Early Multi-Classification of Lung and Colon Cancer Using Histopathological Images
by A. A. Abd El-Aziz, Mahmood A. Mahmood and Sameh Abd El-Ghany
Diagnostics 2024, 14(20), 2274; https://doi.org/10.3390/diagnostics14202274 - 12 Oct 2024
Viewed by 607
Abstract
Background: In recent years, the healthcare field has experienced significant advancements. New diagnostic techniques, treatments, and insights into the causes of various diseases have emerged. Despite these progressions, cancer remains a major concern. It is a widespread illness affecting individuals of all ages [...] Read more.
Background: In recent years, the healthcare field has experienced significant advancements. New diagnostic techniques, treatments, and insights into the causes of various diseases have emerged. Despite these progressions, cancer remains a major concern. It is a widespread illness affecting individuals of all ages and leads to one out of every six deaths. Lung and colon cancer alone account for nearly two million fatalities. Though it is rare for lung and colon cancers to co-occur, the spread of cancer cells between these two areas—known as metastasis—is notably high. Early detection of cancer greatly increases survival rates. Currently, histopathological image (HI) diagnosis and appropriate treatment are key methods for reducing cancer mortality and enhancing survival rates. Digital image processing (DIP) and deep learning (DL) algorithms can be employed to analyze the HIs of five different types of lung and colon tissues. Methods: Therefore, this paper proposes a refined DL model that integrates feature fusion for the multi-classification of lung and colon cancers. The proposed model incorporates three DL architectures: ResNet-101V2, NASNetMobile, and EfficientNet-B0. Each model has limitations concerning variations in the shape and texture of input images. To address this, the proposed model utilizes a concatenate layer to merge the pre-trained individual feature vectors from ResNet-101V2, NASNetMobile, and EfficientNet-B0 into a single feature vector, which is then fine-tuned. As a result, the proposed DL model achieves high success in multi-classification by leveraging the strengths of all three models to enhance overall accuracy. This model aims to assist pathologists in the early detection of lung and colon cancer with reduced effort, time, and cost. The proposed DL model was evaluated using the LC25000 dataset, which contains colon and lung HIs. The dataset was pre-processed using resizing and normalization techniques. Results: The model was tested and compared with recent DL models, achieving impressive results: 99.8% for precision, 99.8% for recall, 99.8% for F1-score, 99.96% for specificity, and 99.94% for accuracy. Conclusions: Thus, the proposed DL model demonstrates exceptional performance across all classification categories. Full article
(This article belongs to the Special Issue Machine-Learning-Based Disease Diagnosis and Prediction)
Show Figures

Figure 1

Figure 1
<p>40× Tissue samples of the LC25000 dataset: (<b>a</b>) NSCLC, (<b>b</b>) SCLC, (<b>c</b>) benign lung tissue, (<b>d</b>) colon cancer tissue, and (<b>e</b>) benign colon tissue.</p>
Full article ">Figure 2
<p>The steps of the proposed DL model.</p>
Full article ">Figure 3
<p>The overall model architecture.</p>
Full article ">Figure 4
<p>The ResNet-101V2’s architecture.</p>
Full article ">Figure 5
<p>The architecture of the reduction cell and NASNet normal.</p>
Full article ">Figure 6
<p>The architecture of EfficientNet-B0.</p>
Full article ">Figure 7
<p>Training and validation loss of the three CNN models and the proposed fusion model.</p>
Full article ">Figure 8
<p>Training and validation accuracy of the three CNN models and the proposed fusion model.</p>
Full article ">Figure 9
<p>The confusion matrix for the three CNN models and the proposed fusion model on the test set.</p>
Full article ">
20 pages, 610 KiB  
Article
Comparative Study of Computational Methods for Classifying Red Blood Cell Elasticity
by Hynek Bachratý, Peter Novotný, Monika Smiešková, Katarína Bachratá and Samuel Molčan
Appl. Sci. 2024, 14(20), 9315; https://doi.org/10.3390/app14209315 - 12 Oct 2024
Viewed by 360
Abstract
The elasticity of red blood cells (RBCs) is crucial for their ability to fulfill their role in the blood. Decreased RBC deformability is associated with various pathological conditions. This study explores the application of machine learning to predict the elasticity of RBCs using [...] Read more.
The elasticity of red blood cells (RBCs) is crucial for their ability to fulfill their role in the blood. Decreased RBC deformability is associated with various pathological conditions. This study explores the application of machine learning to predict the elasticity of RBCs using both image data and detailed physical measurements derived from simulations. We simulated RBC behavior in a microfluidic channel. The simulation results provided the basis for generating data on which we applied machine learning techniques. We analyzed the surface-area-to-volume ratio of RBCs as an indicator of elasticity, employing statistical methods to differentiate between healthy and diseased RBCs. The Kolmogorov–Smirnov test confirmed significant differences between healthy and diseased RBCs, though distinctions among different types of diseased RBCs were less clear. We used decision tree models, including random forests and gradient boosting, to classify RBC elasticity based on predictors derived from simulation data. The comparison of the results with our previous work on deep neural networks shows improved classification accuracy in some scenarios. The study highlights the potential of machine learning to automate and enhance the analysis of RBC elasticity, with implications for clinical diagnostics. Full article
(This article belongs to the Special Issue Artificial Intelligence (AI) Technologies in Biomedicine)
Show Figures

Figure 1

Figure 1
<p>Summary of the framework. Blue and magenta arrows represent actions performed with training and evaluation data, respectively. Blue boxes represent input/output; orange boxes represent actions performed with the data.</p>
Full article ">Figure 2
<p>On the left, microfluidic channel topology is shown. Only the basic part with five obstacles (depicted with blue colour) was simulated. The figure on the right shows the scheme of the simulation box with the dimensions of the individual parts.</p>
Full article ">Figure 3
<p>Time series plot of surface-area-to-volume (<math display="inline"><semantics> <mrow> <mi>S</mi> <mi>A</mi> <mo>:</mo> <mi>V</mi> </mrow> </semantics></math>) ratio for a single healthy RBC.</p>
Full article ">Figure 4
<p>Minimum, maximum, and average <math display="inline"><semantics> <mrow> <mi>S</mi> <mi>A</mi> <mo>:</mo> <mi>V</mi> </mrow> </semantics></math> ratio for nine healthy RBCs. Cells are sorted by average.</p>
Full article ">Figure 5
<p>Average, minimum, maximum, and variance of <math display="inline"><semantics> <mrow> <mi>S</mi> <mi>A</mi> <mo>:</mo> <mi>V</mi> </mrow> </semantics></math> ratio for all 4 cell types. Cells of each type are sorted by the observed characteristic for each plot.</p>
Full article ">Figure 6
<p>Variance of surface area and volume for cell types 0 and 3.</p>
Full article ">Figure 7
<p>Dependence of classification results on <span class="html-italic">S</span> when predicting 4 classes.</p>
Full article ">Figure 8
<p>Dependence of classification results on <span class="html-italic">S</span> when predicting 2 classes.</p>
Full article ">Figure 9
<p>Dependence of classification results on predictor set when predicting 4 classes.</p>
Full article ">Figure 10
<p>Dependence of classification results on predictor set when predicting 2 classes.</p>
Full article ">Figure 11
<p>Importance of predictors from the 6th set.</p>
Full article ">Figure 12
<p>Importance of predictors from the 4th set.</p>
Full article ">
14 pages, 980 KiB  
Article
The Putative Role of TIM-3 Variants in Polyendocrine Autoimmunity: Insights from a WES Investigation
by Andrea Ariolli, Emanuele Agolini, Tommaso Mazza, Francesco Petrizzelli, Stefania Petrini, Valentina D’Oria, Annamaria Cudini, Caterina Nardella, Vanessa Pesce, Donatella Comparcola, Marco Cappa and Alessandra Fierabracci
Int. J. Mol. Sci. 2024, 25(20), 10994; https://doi.org/10.3390/ijms252010994 - 12 Oct 2024
Viewed by 438
Abstract
Autoimmune polyglandular syndrome (APS) comprises a complex association of autoimmune pathological conditions. APS Type 1 originates from loss-of-function mutations in the autoimmune regulator (AIRE) gene. APS2, APS3 and APS4 are linked to specific HLA alleles within the major histocompatibility complex, with [...] Read more.
Autoimmune polyglandular syndrome (APS) comprises a complex association of autoimmune pathological conditions. APS Type 1 originates from loss-of-function mutations in the autoimmune regulator (AIRE) gene. APS2, APS3 and APS4 are linked to specific HLA alleles within the major histocompatibility complex, with single-nucleotide polymorphisms (SNPs) in non-HLA genes also contributing to disease. In general, variability in the AIRE locus and the presence of heterozygous loss-of-function mutations can impact self-antigen presentation in the thymus. In this study, whole-exome sequencing (WES) was performed on a sixteen-year-old female APS3A/B patient to investigate the genetic basis of her complex phenotype. The analysis identified two variants (p.Arg111Trp and p.Thr101Ile) of the hepatitis A virus cell receptor 2 gene (HAVCR2) encoding for the TIM-3 (T cell immunoglobulin and mucin domain 3) protein. These variants were predicted, through in silico analysis, to impact protein structure and stability, potentially influencing the patient’s autoimmune phenotype. While confocal microscopy analysis revealed no alteration in TIM-3 fluorescence intensity between the PBMCs isolated from the patient and those of a healthy donor, RT-qPCR showed reduced TIM-3 expression in the patient’s unfractionated PBMCs. A screening conducted on a cohort of thirty APS patients indicated that the p.Thr101Ile and p.Arg111Trp mutations were unique to the proband. This study opens the pathway for the search of TIM-3 variants possibly linked to complex autoimmune phenotypes, highlighting the potential of novel variant discovery in contributing to APS classification and diagnosis. Full article
(This article belongs to the Section Molecular Immunology)
Show Figures

Figure 1

Figure 1
<p>Homology model of the human TIM-3 protein. The Arg residue (site of the p.Arg111Trp mutation) and Thr (site of the p.Thr101Ile mutation) are indicated by red sticks.</p>
Full article ">Figure 2
<p>Molecular dynamics simulations. Snapshots of RMSF (root mean square fluctuation) values of molecular dynamics simulations of the R111W and the T101I variants and the wild-type TIM-3 protein are shown.</p>
Full article ">Figure 3
<p>RT-qPCR analysis of TIM3 expression in PBMCs isolated from two healthy donors and the patient carrying p.Arg111Trp and p.Thr101Ile variants. Gene expression levels were normalized to GAPDH.</p>
Full article ">
5 pages, 554 KiB  
Proceeding Paper
Detection of Alzheimer’s and Parkinson’s Diseases Using Deep Learning-Based Various Transformers Models
by Mesut Güven
Eng. Proc. 2024, 73(1), 4; https://doi.org/10.3390/engproc2024073004 - 11 Oct 2024
Viewed by 151
Abstract
Alzheimer’s disease is a neurodegenerative condition primarily attributed to environmental factors, abnormal protein deposits, immune system dysregulation, and the consequential death of nerve cells in the brain. On the other hand, Parkinson’s disease manifests as a neurological disorder featuring primary motor, secondary motor, [...] Read more.
Alzheimer’s disease is a neurodegenerative condition primarily attributed to environmental factors, abnormal protein deposits, immune system dysregulation, and the consequential death of nerve cells in the brain. On the other hand, Parkinson’s disease manifests as a neurological disorder featuring primary motor, secondary motor, and non-motor symptoms, accompanied by the rapid demise of cells in the brain’s dopamine-producing region. Utilizing brain images for accurate diagnosis and treatment is integral to addressing both conditions. This study harnessed the power of artificial intelligence for classification processes, employing state-of-the-art transformer models such as Swin transformer, vision transformer (ViT), and bidirectional encoder representation from image transformers (BEiT). The investigation utilized an open-source dataset comprising 450 images, evenly distributed among healthy, Alzheimer’s, and Parkinson’s classes. The dataset was meticulously divided, with 80% allocated to the training set (390 images) and 20% to the validation set (90 images). Impressively, the classification accuracy surpassed 80%, showcasing the efficacy of transformer-based models in disease detection. Looking ahead, this study recommends delving into hybrid and ensemble models and leveraging the strengths of multiple transformer-based deep learning architectures. Beyond contributing crucial insights at the intersection of artificial intelligence and neurology, this research emphasizes the transformative potential of advanced models for enhancing diagnostic precision and treatment strategies in Alzheimer’s and Parkinson’s diseases. It signifies a significant step towards integrating cutting-edge technology into mainstream medical practices for improved patient outcomes. Full article
(This article belongs to the Proceedings of The 4th International Electronic Conference on Biosensors)
Show Figures

Figure 1

Figure 1
<p>Flowchart of Alzheimer’s and Parkinson’s disease classification.</p>
Full article ">Figure 2
<p>Multi-class classification results.</p>
Full article ">
17 pages, 17639 KiB  
Article
Intravenous Infusion of Autologous Mesenchymal Stem Cells Expanded in Auto Serum for Chronic Spinal Cord Injury Patients: A Case Series
by Ryosuke Hirota, Masanori Sasaki, Satoshi Iyama, Kota Kurihara, Ryunosuke Fukushi, Hisashi Obara, Tsutomu Oshigiri, Tomonori Morita, Masahito Nakazaki, Takahiro Namioka, Ai Namioka, Rie Onodera, Yuko Kataoka-Sasaki, Shinichi Oka, Mitsuhiro Takemura, Ryo Ukai, Takahiro Yokoyama, Yuichi Sasaki, Tatsuro Yamashita, Masato Kobayashi, Yusuke Okuma, Reiko Kondo, Ryo Aichi, Satoko Ohmatsu, Noritaka Kawashima, Yoichi M. Ito, Masayoshi Kobune, Kohichi Takada, Sumio Ishiai, Toru Ogata, Atsushi Teramoto, Toshihiko Yamashita, Jeffery D. Kocsis and Osamu Honmouadd Show full author list remove Hide full author list
J. Clin. Med. 2024, 13(20), 6072; https://doi.org/10.3390/jcm13206072 - 11 Oct 2024
Viewed by 496
Abstract
Objective: The safety, feasibility, and potential functional improvement following the intravenous infusion of mesenchymal stem cells (MSCs) were investigated in patients with chronic severe spinal cord injury (SCI). Methods: The intravenous infusion of autologous MSCs cultured in auto-serum under Good Manufacturing Practices (GMP) [...] Read more.
Objective: The safety, feasibility, and potential functional improvement following the intravenous infusion of mesenchymal stem cells (MSCs) were investigated in patients with chronic severe spinal cord injury (SCI). Methods: The intravenous infusion of autologous MSCs cultured in auto-serum under Good Manufacturing Practices (GMP) was administered to seven patients with chronic SCI (ranging from 1.3 years to 27 years after the onset of SCI). In addition to evaluating feasibility and safety, neurological function was evaluated using the American Spinal Injury Association Impairment Scale (AIS), International Standards for Neurological Classification of Spinal Cord Injury (ISCSCI-92), and Spinal Cord Independence Measure III (SCIM-III). Results: No serious adverse events occurred. Neither CNS tumors, abnormal cell growth, nor neurological deterioration occurred in any patients. While this initial case series was not blinded, significant functional improvements and increased quality of life (QOL) were observed at 90 and 180 days post-MSC infusion compared to pre-infusion status. One patient who had an AIS grade C improved to grade D within six months after MSC infusion. Conclusions: This case series suggests that the intravenous infusion of autologous MSCs is a safe and feasible therapeutic approach for chronic SCI patients. Furthermore, our data showed significant functional improvements and better QOL after MSC infusion in patients with chronic SCI. A blind large-scale study will be necessary to fully evaluate this possibility. Full article
(This article belongs to the Section Clinical Neurology)
Show Figures

Figure 1

Figure 1
<p>Clinical protocol.</p>
Full article ">Figure 2
<p>Case 1. T2-weighted MRI. (<b>A</b>) Sagittal arrows indicate the high-intensity areas. (<b>B</b>) Axial images. The arrowhead indicates the high-intensity areas. (<b>C</b>) Sensory function (pre, post 6M), (<b>D</b>) motor function, (<b>E</b>) sensory function, and (<b>F</b>) SCIM-III score.</p>
Full article ">Figure 3
<p>Case 2. T2-weighted MRI. (<b>A</b>) Sagittal arrows indicate the high-intensity areas. (<b>B</b>) Axial images. The arrowhead indicates the high-intensity areas. (<b>C</b>) Sensory function (pre, post 6M), (<b>D</b>) motor function, (<b>E</b>) sensory function, and (<b>F</b>) SCIM-III score.</p>
Full article ">Figure 4
<p>Case 3. T2-weighted MRI. (<b>A</b>) Sagittal arrows indicate the high-intensity areas. (<b>B</b>) Axial images. The arrowhead indicates the high-intensity areas. (<b>C</b>) Sensory function (pre, post 6M), (<b>D</b>) motor function, (<b>E</b>) sensory function, and (<b>F</b>) SCIM-III score.</p>
Full article ">Figure 5
<p>Case 4. T2-weighted MRI. (<b>A</b>) Sagittal arrows indicate the high-intensity areas. (<b>B</b>) Axial images. The arrowhead indicates the high-intensity areas. (<b>C</b>) Sensory function (pre, post 6M), (<b>D</b>) motor function, (<b>E</b>) sensory function, and (<b>F</b>) SCIM-III score.</p>
Full article ">Figure 6
<p>Case 5. T2-weighted MRI. (<b>A</b>) Sagittal arrows indicate the high-intensity areas. (<b>B</b>) Axial images. The arrowhead indicates the high-intensity areas. (<b>C</b>) Sensory function (pre, post 6M), (<b>D</b>) motor function, (<b>E</b>) sensory function, and (<b>F</b>) SCIM-III score.</p>
Full article ">Figure 7
<p>Case 6. T2-weighted MRI. (<b>A</b>) Sagittal arrows indicate the high-intensity areas. (<b>B</b>) Axial images. The arrowhead indicates the high-intensity areas. (<b>C</b>) Sensory function (pre, post 6M), (<b>D</b>) motor function, (<b>E</b>) sensory function, and (<b>F</b>) SCIM-III score.</p>
Full article ">Figure 8
<p>Case 7. T2-weighted MRI. (<b>A</b>) Sagittal arrows indicate the high-intensity areas. (<b>B</b>) Axial images. The arrowhead indicates the high-intensity areas. (<b>C</b>) Sensory function (pre, post 6M), (<b>D</b>) motor function, (<b>E</b>) sensory function, and (<b>F</b>) SCIM-III score.</p>
Full article ">Figure 9
<p>Outcome measure scores according to AIS C classification ((<b>A</b>): motor; (<b>B</b>): sensory; (<b>C</b>): SCIM-III) prior to MSC infusion, 90 and 180 days post-MSC infusion.</p>
Full article ">Figure 10
<p>Comparison of outcome measure scores before infusion and six months post-MSC infusion based on AIS classification ((<b>A</b>,<b>D</b>): motor; (<b>B</b>,<b>E</b>): sensory; (<b>C</b>,<b>F</b>): SCIM-III).</p>
Full article ">
16 pages, 2272 KiB  
Article
Augmenting Multimodal Content Representation with Transformers for Misinformation Detection
by Jenq-Haur Wang, Mehdi Norouzi and Shu Ming Tsai
Big Data Cogn. Comput. 2024, 8(10), 134; https://doi.org/10.3390/bdcc8100134 - 11 Oct 2024
Viewed by 461
Abstract
Information sharing on social media has become a common practice for people around the world. Since it is difficult to check user-generated content on social media, huge amounts of rumors and misinformation are being spread with authentic information. On the one hand, most [...] Read more.
Information sharing on social media has become a common practice for people around the world. Since it is difficult to check user-generated content on social media, huge amounts of rumors and misinformation are being spread with authentic information. On the one hand, most of the social platforms identify rumors through manual fact-checking, which is very inefficient. On the other hand, with an emerging form of misinformation that contains inconsistent image–text pairs, it would be beneficial if we could compare the meaning of multimodal content within the same post for detecting image–text inconsistency. In this paper, we propose a novel approach to misinformation detection by multimodal feature fusion with transformers and credibility assessment with self-attention-based Bi-RNN networks. Firstly, captions are derived from images using an image captioning module to obtain their semantic descriptions. These are compared with surrounding text by fine-tuning transformers for consistency check in semantics. Then, to further aggregate sentiment features into text representation, we fine-tune a separate transformer for text sentiment classification, where the output is concatenated to augment text embeddings. Finally, Multi-Cell Bi-GRUs with self-attention are used to train the credibility assessment model for misinformation detection. From the experimental results on tweets, the best performance with an accuracy of 0.904 and an F1-score of 0.921 can be obtained when applying feature fusion of augmented embeddings with sentiment classification results. This shows the potential of the innovative way of applying transformers in our proposed approach to misinformation detection. Further investigation is needed to validate the performance on various types of multimodal discrepancies. Full article
Show Figures

Figure 1

Figure 1
<p>System architecture of the proposed approach to misinformation detection.</p>
Full article ">Figure 2
<p>The architecture of the image captioning module as adapted from [<a href="#B26-BDCC-08-00134" class="html-bibr">26</a>].</p>
Full article ">Figure 3
<p>Fine-tuning BERT model in two different downstream tasks: (<b>a</b>) next-sentence prediction task; (<b>b</b>) single-sentence classification task [<a href="#B2-BDCC-08-00134" class="html-bibr">2</a>].</p>
Full article ">Figure 4
<p>Two different ways of stacking multiple layers of RNN cells: (<b>a</b>) Multi-Cell BiRNN; (<b>b</b>) Multi-Layer Bi-RNN [<a href="#B25-BDCC-08-00134" class="html-bibr">25</a>].</p>
Full article ">Figure 4 Cont.
<p>Two different ways of stacking multiple layers of RNN cells: (<b>a</b>) Multi-Cell BiRNN; (<b>b</b>) Multi-Layer Bi-RNN [<a href="#B25-BDCC-08-00134" class="html-bibr">25</a>].</p>
Full article ">Figure 5
<p>The effects of different types of RNNs for credibility assessment on misinformation detection (with only text features) [<a href="#B14-BDCC-08-00134" class="html-bibr">14</a>,<a href="#B25-BDCC-08-00134" class="html-bibr">25</a>].</p>
Full article ">Figure 6
<p>The effects of different types of RNNs for credibility assessment on misinformation detection (with all features) [<a href="#B14-BDCC-08-00134" class="html-bibr">14</a>,<a href="#B25-BDCC-08-00134" class="html-bibr">25</a>].</p>
Full article ">Figure 7
<p>The visual representation of the fake and real posts (<b>a</b>) without fine-tuning transformers and (<b>b</b>) with fine-tuning transformers.</p>
Full article ">
12 pages, 2167 KiB  
Article
Optimizing Scorpion Toxin Processing through Artificial Intelligence
by Adam Psenicnik, Andres A. Ojanguren-Affilastro, Matthew R. Graham, Mohamed K. Hassan, Mohamed A. Abdel-Rahman, Prashant P. Sharma and Carlos E. Santibáñez-López
Toxins 2024, 16(10), 437; https://doi.org/10.3390/toxins16100437 - 11 Oct 2024
Viewed by 432
Abstract
Scorpion toxins are relatively short cyclic peptides (<150 amino acids) that can disrupt the opening/closing mechanisms in cell ion channels. These peptides are widely studied for several reasons including their use in drug discovery. Although improvements in RNAseq have greatly expedited the discovery [...] Read more.
Scorpion toxins are relatively short cyclic peptides (<150 amino acids) that can disrupt the opening/closing mechanisms in cell ion channels. These peptides are widely studied for several reasons including their use in drug discovery. Although improvements in RNAseq have greatly expedited the discovery of new scorpion toxins, their annotation remains challenging, mainly due to their small size. Here, we present a new pipeline to annotate toxins from scorpion transcriptomes using a neural network approach. This pipeline implements basic neural networks to sort amino acid sequences to find those that are likely toxins and thereafter predict the type of toxin represented by the sequence. We anticipate that this pipeline will accelerate the classification of scorpion toxins in forthcoming scorpion genome sequencing projects and potentially serve a useful role in identifying targets for drug development. Full article
(This article belongs to the Section Animal Venoms)
Show Figures

Figure 1

Figure 1
<p>Length cut-off effect on training data and <span class="html-italic">tapai</span> performance. (<b>A</b>) Validation accuracy for different peptide truncation/padding lengths. Results of sequence truncation length on the validation accuracy of the toxin model. (<b>B</b>) Confusion matrix showing <span class="html-italic">tapai</span> performance with the complete dataset (validation and testing sets). (<b>C</b>) Confusion matrix showing <span class="html-italic">tapai</span> performance with sequence truncation length to 128 residues. Color intensity in (<b>B</b>,<b>C</b>) represents the percentage of correct classifications for each combination of predicted and actual classes. Four additional toxin models were created with the TV layer truncating or padding to 16, 32, 64, and 256 residues, and trained using the same hyperparameters (<a href="#app1-toxins-16-00437" class="html-app">Figure S1</a>).</p>
Full article ">Figure 2
<p>BLAST sequence similarity and <span class="html-italic">tapai</span> performance. (<b>A</b>) The distribution of percentage of similarity and e-values from the initial BLAST analysis plotted as a function of type of toxin (ICK: red, KTx: green, NaTx: blue). (<b>B</b>) Confusion matrix showing the classification performance of <span class="html-italic">tapai</span> in comparison to BLAST similarity predictions.</p>
Full article ">Figure 3
<p>Multiple sequence alignment (MSA) of transcripts classified by <span class="html-italic">tapai</span> as (<b>A</b>) NaTx with “only insect” affinity, (<b>B</b>) NaTx with “only mammal” affinity (all from buthid scorpions), and (<b>C</b>) calcins (all from iurid scorpions). Top sequences (those with accession numbers) on each MSA were retrieved from the UniProt. Consensus sequence histograms are found below each MSA (red color indicates the conservative cysteine pattern).</p>
Full article ">
Back to TopTop